Predicting drug sensitivity of cancer cells based on DNA methylation levels.
Cancer cell lines, which are cell cultures derived from tumor samples, represent one of the least expensive and most studied preclinical models for drug development. Accurately predicting drug responses for a given cell line based on molecular features may help to optimize drug-development pipelines...
Guardado en:
Autores principales: | Sofia P Miranda, Fernanda A Baião, Julia L Fleck, Stephen R Piccolo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cda66912ff464280b536bf53c158d2e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Artificial neural network, predictor variables and sensitivity threshold for DNA methylation-based age prediction using blood samples
por: Zhonghui Thong, et al.
Publicado: (2021) -
DNA methylation landscape of 16 canine somatic tissues by methylation-sensitive restriction enzyme-based next generation sequencing
por: Jumpei Yamazaki, et al.
Publicado: (2021) -
Author Correction: Artificial neural network, predictor variables and sensitivity threshold for DNA methylation-based age prediction using blood samples
por: Zhonghui Thong, et al.
Publicado: (2021) -
Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
por: Xianyu Zhang, et al.
Publicado: (2021) -
A novel methylation signature predicts radiotherapy sensitivity in glioma
por: Yuemei Feng, et al.
Publicado: (2020)